The pharmacodynamics of i.v. and subcutaneous (s.c.) tinzaparin sodium compared with heparin in healthy volunteers were studied. A randomized, open-label, five-treatment, five-period-crossover ...

Routine heparinization might reduce the likelihood of renal allograft thrombosis, but some investigators claim that this approach increases morbidity without exerting beneficial effects.

Heparin is administered via subcutaneous injection or intravenous infusion, depending on the condition. Major players include Baxter International's Optimvia, which offers both bovine and porcine ...

The pharmacodynamics of tinzaparin 4500 IU s.c. (treatment E) and s.c. heparin (treatment A) are compared in Figure 4. Intersubject variability for tinzaparin AUAC 0-t and AUAC 0- (16-27% ...